Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05155891 · ClinicalTrials.gov registry record · NA

Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate

A NA study of Benign Prostatic Hyperplasia, sponsored by University of Miami.

Active
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT05155891 is a NA study of Benign Prostatic Hyperplasia that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 45 participants, below the 551-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05155891, a NA study of Benign Prostatic Hyperplasia, is active but no longer recruiting, sponsored by University of Miami.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to evaluate prostate artery embolization (PAE) compared to Holmium laser enucleation of prostate (HoLEP) in improving a patient's overall prostate related symptoms.

Conditions Studied

Benign Prostatic Hyperplasia

Interventions

  • DEVICE Embosphere Microspheres
  • PROCEDURE HoLEP Procedure

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2022-06-17
Est. Completion 2027-01-01
Phase NA

Sponsor

University of Miami

721 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05155891

The ClinicalTrials.gov registry entry for NCT05155891 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 551-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (92% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 2 interventions - of which Embosphere Microspheres is the first listed.

NCT05155891 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05155891 about?

NCT05155891 is a clinical study titled "Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate". The purpose of this research study is to evaluate prostate artery embolization (PAE) compared to Holmium laser enucleation of prostate (HoLEP) in improving a patient's overall prostate related symptoms.

What is the current status of trial NCT05155891?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2022-06-17. Estimated completion is 2027-01-01.

What conditions does trial NCT05155891 study?

This clinical trial studies the following conditions: Benign Prostatic Hyperplasia.

What interventions are being tested in trial NCT05155891?

The interventions under investigation include: Embosphere Microspheres (DEVICE), HoLEP Procedure (PROCEDURE).

Who is sponsoring clinical trial NCT05155891?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05155891 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Benign Prostatic Hyperplasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Benign Prostatic Hyperplasia

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.